Walter H Lang Selected Research

dehydroergosterol

1/2019

Identification of Biologically Active Ganoderma lucidum Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter H Lang Research Topics

Disease

6	Neoplasms (Cancer) 05/2019 - 01/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Genomic Instability 01/2014
1	Neuroblastoma 01/2014

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 05/2019 - 01/2019
2	ergosterol-5,8-peroxideIBA 01/2019 - 01/2019
1	Pharmaceutical PreparationsIBA 05/2019
1	Cytostatic AgentsIBA 05/2019
1	Protein Synthesis InhibitorsIBA 05/2019
1	HomoharringtonineIBA 05/2019
1	AlkaloidsIBA 05/2019
1	dehydroergosterolIBA 01/2019
1	jatrophaneIBA 01/2019
1	Ergosterol (Lumisterol)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Cyclin D1IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013
1	tyrosine receptor (receptor, tyrosine)IBA 01/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013

Therapy/Procedure

2	Therapeutics 12/2013 - 01/2013